Pluripotent stem cells represent one promising source for cell replacement therapy in heart. but differentiating embryonic stem cell-derived cardiomyocytes (ESC-CMs) are highly heterogeneous and show a variety of maturation states. In this study. we employed an ESC clonal line that contains a cardiac-restricted ncx1 promoter-driven puromycin resistance cassette together with a mass cu... https://giantrobos.shop/product-category/in-print/